BETA
Preparing to launch a trocar-compatible suture-management device for laparoscopic and robotic surgery.
Endospool is a surgical device business associated with Swope Surgical, developing a compact system for managing sutures during laparoscopic and robotic procedures. Its team includes surgeon-inventor Dr. G. Swope Munday, co-founder and CEO John Hart, and colorectal surgeon Dr. Anthony Senagore. A company headquarters city was not established in the reviewed sources.
The device stores suture in a capsule with internal spindles, a loading winder and a retrieval string. It is designed for introduction through a trocar of at least 8 mm and use with existing minimally invasive instruments. Its intended value is more organized suture handling; reductions in operative time, retained material or complications were not independently validated in the reviewed evidence.
The current launch-update page says the product is about to launch, while its brochure remains labeled for demonstration use only. The company describes an anticipated Class I / 510(k)-exempt pathway, which was not independently confirmed. It reports 23 issued patents across several markets; a reviewed U.S. patent names Munday as inventor. Assut Europe publicly showed Endospool with Filbloc at SAGES 2026, documenting a demonstration rather than routine clinical adoption.
Endospool’s suture-management system remains in development. The manufacturer anticipates a Class I, 510(k)-exempt route, but no product-matched FDA classification or exemption determination was established. A proposed pathway is not a completed authorization. [13][8][1]
No matching FDA recall event was identified in the completed company/applicant, linked-identifier and product-name searches. [5][3]
Latest recorded source review: 2026-10-20.
Scope: selected product families.
No commercially marketed product portfolio has been established in the reviewed material.
Capsule with internal spindles, loading winder and retrieval string for organized suture introduction, delivery and removal. Manufacturer specifies trocar diameter of 8 mm or greater. [11][13][9][14]
Investigational / in developmentPrelaunch update form on current website. Manufacturer brochure states demonstration use only / not for sale.
US11701104B2, Apparatus for closing a surgical site, was granted with George Swope Munday named as inventor. Patent status does not establish FDA authorization or company ownership. [7]
Accessed 10/20/2026